Jiwa Bio-Pharm Holdings Limited has sold a majority stake to U-Home Group International Ltd.
U-Home Group International Litd. has acquired 72.19% of the issued share capital in Jiwa Bio-Pharm Holdings Limited, for a consideration of US$35.9 million.
The company trades in pharmaceutical and healthcare products, research and development of chemical and biological products, and investment and treasury functions.
U-Home Group International Ltd. is a company owned by Yuhua Enterprises Co Ltd.
Oaklins' team in Hong Kong acted as financial advisor to Jiwa Bio-Pharm Holdings Limited regarding this transaction.
Talk to the deal team
Related deals
Apotheka acquires two pharmacy outlets from Panpharmacy
In a strategic move that signifies the ongoing consolidation and growth within the Latvian pharmaceutical retail sector, Panpharmacy, the parent company of the leading online pharmacy InternetAptieka.lv, has successfully completed the sale of two of its brick-and-mortar pharmacies to Apotheka. These pharmacies, both situated in the capital city of Riga, will continue to serve customers under the Apotheka brand, marking a seamless transition in ownership and operations.
Learn moreRogan’s Shoes has been acquired by Shoe Carnival
The owners of Rogan’s Shoe have sold the company to Shoe Carnival, Inc. This acquisition provides Shoe Carnival a well-scaled entry into the Wisconsin market and a complementary growth channel in work boot and safety footwear.
Learn moreTrive Capital acquires Ten Entertainment Group
Trive Capital has acquired Ten Entertainment Group Ltd.
Learn more